Vanessa Yen
`
`Partner
`Trial and Global Disputes
`
`New York: +1 212 556 2212
`vyen@kslaw.com
`
`Vanessa Yen is a partner and trial lawyer in the Intellectual Property, Patent, Trademark and
`Copyright Litigation group. She focuses her practice on complex, high-stakes patent litigations, and
`intellectual property transactions, counseling, and disputes. Vanessa has never lost a trial on behalf
`of her clients. Considered one of the “world’s leading patent professionals” with “exceptional skill
`sets and profound insights into patent matters” while “maintaining clear strategic vision,” Vanessa
`was recognized as such by IAM Patent 1000.
`
`As an MIT graduate, Vanessa is focused on handling intellectual property patent matters for clients
`in the technology, life sciences, pharma, and chemical industries. Vanessa’s representative clients
`and matters includes work done for companies from around the world, such as: GlaxoSmithKline,
`GW Pharma, Alexion, Bristol Myers Squibb, Galderma, Sword Health, Sunovion, Shire LLC,
`Supernus, AstraZeneca, Gilead, UCB, Celltech, Eisai, Canon and Novartis.
`
`Experienced with bench and jury patent trials before U.S. district courts, the U.S. Court of Appeals
`for the Federal Circuit and the PTAB, Vanessa has deep litigation experience handling
`pharmaceutical and biologics/biosimilars patent litigations, including for blockbuster products with
`multi-billion dollar sales. She has handled IP matters concerning various technologies, including
`products and treatments for cancer, HIV/AIDS, skin care and dermatology, femtech, prostate
`disorders, genetic vector technology and molecular cloning, musculoskeletal disorders, autoimmune
`and neurological disorders.
`
`Named as one of the Top Women Attorneys in New York metro and a Top Rated Intellectual
`Property Litigation Attorney, Vanessa provides her clients with an array of IP services beyond
`patent litigation, including licensing and due diligence advice, strategic assessment of IP assets and
`IP portfolios for potential mergers & acquisitions, freedom to operate opinions, and others.
`
`Vanessa has handled one of the Top Litigations and Disputes of 2019 (recognized by Financial
`Times) and achieved a patent litigation victory that was named Hatch Waxman Impact Case of the
`Year (recognized by LMG Life Sciences). She was also part of the team that obtained the first IPR
`victory for an Orange Book-listed patent dispute that was involved in parallel Federal district court
`litigation.
`
`Committed to diversity and inclusion, Vanessa co-leads K&S's Asian Affinity Group, and is an
`
`www.kslaw.com
`
`SERVIER-2002
`IPR2022-01423
`
`1
`
`1
`
`

`

`active member of NAPABA, GABAPA, AALDEF and AABANY.
`
`Prior to law, Vanessa spent years conducting breast cancer research and genetics/genomic research
`while at MIT. She also worked at a top U.S. strategic management consulting firm.
`
`Matters
`Alexion Pharmaceuticals in several patent litigation disputes before the PTAB involving Soliris®,
`a multi-billion dollar biologic product
`
`Bristol Myers Squibb in connection with a patent litigation involving CAR-T related biotech for
`cancer immunotherapy; in connection with patent litigation dispute matters for BMS's other cancer
`therapies
`
`Galderma in a patent litigation and IPRs involving Oracea®, a product for rosacea with over a
`billion dollars in sales
`
`GW Pharma / Jazz Pharma in a complex and international litigation and arbitration contract
`dispute concerning patent disputes involving Epidiolex®, a cannabidiol for Dravet and LGS
`
`Sword Health in a patent litigation involving digital musculoskeletal therapy
`
`Sunovion Pharmaceuticals Inc. in a patent litigation involving Brovana®, a chronic obstructive
`pulmonary disease drug product
`
`Shire LLC and Supernus Pharmaceuticals, Inc. in a patent litigation involving Intuniv®, a
`treatment for ADHD
`
`Eisai Co., Ltd. in a patent litigation involving Banzel®, an antiepileptic drug product
`
`AstraZeneca in a patent litigation involving Seroquel®, an antipsychotic drug product
`
`Gilead Sciences in a patent litigation involving Truvada®, an anti-HIV-1 drug product
`
`Novartis Pharmaceuticals in a patent litigation involving Trileptal®, a product for the treatment of
`partial seizures
`
`UCB and Celltech Pharmaceuticals in a patent litigation involving Metadate CD®, an ADHD drug
`product
`
`Credentials
`EDUCATION
`J.D., Cornell University
`B.S., Massachusetts Institute of Technology
`
`ADMISSIONS
`U.S. Court of Appeals for the Federal Circuit
`New Jersey
`New York
`
`ASSOCIATIONS
`New York Intellectual Property Law Association
`National Association of Women Lawyers
`ChIPs
`
`www.kslaw.com
`
`2
`
`2
`
`

`

`NAPABA
`AALDEF
`AABANY
`GAPABA
`
`LANGUAGES
`Cantonese Hong Kong
`Mandarin Chinese
`
`Recognition
`Top 100 Women Leaders of New York
`
`WOMEN WE ADMIRE, 2022
`
`U.S. Rising Star in Intellectual Property
`
`LMG LIFE SCIENCES, 2021
`
`World's Leading Patent Professionals: Top Patent Professional
`
`IAM PATENTS 1000, 2019-2021
`
`Top Litigations and Disputes of 2019
`
`FINANCIAL TIMES, 2019
`
`Top Women Attorney in New York Metro
`
`SUPER LAWYERS, 2014-2018
`
`Top Rated Intellectual Property Litigation Attorney
`
`SUPER LAWYERS, 2014-2019
`
`Hatch Waxman Impact Case of the Year
`
`LMG LIFE SCIENCES 2019
`
`“Rising Star” in Intellectual Property Litigation
`
`SUPER LAWYERS, 2014-2019
`
`Insights
`ARTICLE
`September 1, 2021 • Source: Intellectual Property & Technology Law Journal
`“Purple Book” Patent Listing Under Biological Product Patent Transparency Act: What Is
`Required, and What to Expect?
`
`CLIENT ALERT
`
`www.kslaw.com
`
`3
`
`3
`
`

`

`April 7, 2021
`“Purple Book” Patent Listing Under Biological Product Patent Transparency Act: What is
`Required, and What to Expect?
`
`February 12, 2021
`GSK v. Teva and Induced Infringement by AB-Rated Generics: Where are we now?
`
`VIEW ALL ON KSLAW.COM
`
`Events
`SPEAKING ENGAGEMENT
`April 26, 2022
`Vanessa Yen to Speak at American Conference Institute’s 17th Annual Paragraph IV Conference
`
`April 27, 2021
`Vanessa Yen, Evan Diamond, Gerald Flattmann to Speak at American Conference Institute’s
`2021 Paragraph IV Disputes Master Symposium
`
`WEBINAR
`November 9, 2021
`King & Spalding Pharmaceutical University 2021
`
`VIEW ALL ON KSLAW.COM
`
`News
`IN THE NEWS
`July 18, 2022 • Source: Law360
`Vanessa Yen and Evan Diamond represent cancer research institutions in U.S. Supreme Court
`amicus briefing on closely-watched patent issues
`
`July 1, 2022 • Source: Law360
`Steven Zager, Gerald Flattmann, Vanessa Yen and Evan Diamond counsel GW Pharmaceuticals
`before the Federal Circuit in a patent infringement dispute
`
`RECOGNITION
`September 23, 2021
`LMG Life Sciences Names King & Spalding its Government Investigations Firm of the Year,
`Honors Partner Vanessa Yen as an Intellectual Property Rising Star
`
`VIEW ALL ON KSLAW.COM
`
`www.kslaw.com
`
`4
`
`4
`
`